Advertisement

International Journal of Pancreatology

, Volume 29, Issue 3, pp 163–171 | Cite as

Effects of mast-cell stabilization in cerulein-induced acute pancreatitis in rats

  • Nadir Yönetçi
  • Nevin OruçEmail author
  • A. Ömer Özütemiz
  • Handan Ak çelik
  • Gül Yüce
Article

Summary

Aim. In this study we aimed to clarify the role of mast cells in the development and progression of inflammation in cerulein-induced acute pancreatitis (AP) in rats. We have also examined the effects of ketotifen; a mast-cell stabilizing agent in the treatment of acute pancreatitis and its relation with nitric oxide (NO) synthesis.

Methods. In the first part of the study we planned to examine the effects mast cell stabilization in acute pancreatitis, while the second part was focused on examining the relation between NO synthesis and the potential effects of ketotifen in AP. Wistar albino rats were randomly divided into 6 groups (n: 10). In the first part of the study, AP was induced by four subcutaneous (sc) injections of 20 µg/kg body weight of cerulein at hourly intervals in Groups A and B while Group C was treated with saline as the control group. Group B was pretreated with ketotifen 1 mg/kg (ip). In the second part, the study design was similar except for the inhibition of nitric oxide synthesis by N-nitro L-arginine methyl ester (L-NAME) 30 mg/kg (ip) in Groups D, E and F. Group D was treated with L-NAME and cerulein and Group E was treated with ketotifen, L-NAME and cerulein. Group F was treated with L-NAME and saline as the control group. Serum amylase activity and pancreatic myeloperoxidase activity (MPO) were measured. Pancreatic histology and mast-cell count in pancreatic tissue were evaluated.

Results. Mast cell count was found to be increased in the pancreatic tissue in cerulein-induced AP. (2.93±0.26 vs 1.98±0.26; p<0.001). Ketotifen treatment significantly reduced cerulein induced edema (1.30±0.21 vs 0.70±0.15; p<0.001), neutrophil infiltration (1.50±0.16 vs 0.60±0.16; p<0.001) and attenuated the increase in amylase (4394.0±149.5 U/L vs 3350.5±216.9 U/L; p<0.05) and MPO activity (1.14±0.13 U/gr tissue vs 0.54±0.08 U/gr tissue; p<0.001). Mast-cell count in pancreatic tissue was also decreased significantly with ketotifen pretreatment (2.93±0.26 vs 1.70±0.21; p<0.05). Inhibition of NO synthesis with L-NAME treatment decreased the beneficial effects of ketotifen.

Conclusion. It seems likely that mast cell activity may play an important role in the initiation and progression of acute pancreatitis. Ketotifen treatment may reduce the severity of AP in rats. The protective action of ketotifen in cerulein-induced acute pancreatitis is most probably owing to mast cell stabilization and stimulation of NO synthesis.

Key Words

Acute pancreatitis ketotifen mast cell Nitric oxide MPO L-NAME 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Banks P. Acute and chronic pancreatitis. In: Sleisenger Fordtran’s Gastrointestinal and Liver Disease, Sixth Edition, W. B. Saunders Company, Philadelphia, 1997; pp. 809–838.Google Scholar
  2. 2.
    Denham W, Norman J. The potential role of therapeutic cytokine manipulation in acute pancreatitis. Surg ClinNorth Am 1999;79:767–781.CrossRefGoogle Scholar
  3. 3.
    Leach SD, Gorelick FS, Modlin IM. Acute pancreatitis at its centenary: The contribution of Reginald Fitz. Ann Surg 1990; 212:109–113.PubMedCrossRefGoogle Scholar
  4. 4.
    Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998;175:76–83.PubMedCrossRefGoogle Scholar
  5. 5.
    Karne S. Etiopathogenesis of acute pancreatitis. Surg Clin North Am 1999;79:699–710.PubMedCrossRefGoogle Scholar
  6. 6.
    Gaboury JP, Johnston B, Niu XF, Kubes P. Mechanisms underlying acute mast cell induced leukocyte rolling and adhesion in vivo. J Immunol 1995;154:804–813.PubMedGoogle Scholar
  7. 7.
    Braganza JM. Mast cell: pivotal player in lethal acute pancreatitis. Q J Med 2000; 93:469–476.Google Scholar
  8. 8.
    Kimura M, Mitani H, Bondoh T, Totsuka T, Hayashi S. Mast cell degranulation in rat mesenteric venule: effects of L-NAME, metylene blue and ketotifen. Pharmacological Research 1999;39:397–402.PubMedCrossRefGoogle Scholar
  9. 9.
    Kubes P, Kanvar S, Niu X-F, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993;7:1293–1299.PubMedGoogle Scholar
  10. 10.
    Kanwar S, Wallace JL, Befus D, Kubes P. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994,266:222–229.Google Scholar
  11. 11.
    Grant SM, Goa KL, Fitton A, Sorkin EM. Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in asthma and allergic disorders. Drugs 1990;40:412–448.PubMedCrossRefGoogle Scholar
  12. 12.
    Kalia N, Bardhan ND, Reed MW, Jacop S, Brown NJ. Mast cell stabilization prevents ethanol induced rat gastric mucosal injury: mechanism of protection. Gastroenterol Hepatol 2000;15:133–141CrossRefGoogle Scholar
  13. 13.
    Eliakim R, Karmeli F, Rachmilewitz D. Ketotifen old drug, new indication. Reduction of gastric mucosal injury. Scand J Gastroenterol 1993;28:202–204.PubMedCrossRefGoogle Scholar
  14. 14.
    Schoenberg MH, Büchler M, Gaspar M, Stinner A, Younes M, Melzner I, et al. Oxygen free radicals in acute pancreatitis of the rat. Gut 1990;31:1138–1143.PubMedCrossRefGoogle Scholar
  15. 15.
    Parwaresch MR, Horny HP, Lennert K. Tissue mast cell in health and disease. Path Res Pract 1985;179:439–461.PubMedGoogle Scholar
  16. 16.
    Masini E, Salvenimi D, Pistelli A, Mannaioni PF, Vane JR. Ratmast cells synthesize a nitric oxide like factor which modulates the release of histamine. Agents Actions 1991;3:61–63.CrossRefGoogle Scholar
  17. 17.
    Klebanoff SJ, Waltersdorph AM, Rosen H. Antimicrobial activity of myeloperoxidase. Meth Enzymol 1984;105:399–403.PubMedCrossRefGoogle Scholar
  18. 18.
    Slater JW, Zechnich AD, Haxby DG. Second-generation antihistamines: acomparative review. Drugs 1999;57:31–47.PubMedCrossRefGoogle Scholar
  19. 19.
    Stevens RL, Austen KF. Recent advances in the cellular and molecular biology of mast cells. Immunol Today 1989;10:381–386.PubMedCrossRefGoogle Scholar
  20. 20.
    Schwartz LB, Huff TF. (1993) Biology of mast cells and basophils. In Allergy Principles and Practice. (Middleton EJ, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds.) Mosby, St. Louis, MO. pp. 135–168.Google Scholar
  21. 21.
    Sanfey H, Bulkley GB, Cameron JL. The pathogenesis of acute pancreatitis. The source and role of oxygen-derived free radicals in three different experimental models. Ann Surg 1985;201:633–639.PubMedCrossRefGoogle Scholar
  22. 22.
    Vural KM, Liao H, Oz MC, Pinsky DJ. Effects of mast cell membrane stabilizing agents in a rat lung ischemia-reperfusion model. Ann Thorac Surg 2000;69:228–231.PubMedCrossRefGoogle Scholar
  23. 23.
    Karmeli F, Eliakim R, Okon E, Rachmilewitz D. Gastic mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. 1991;100:1206–1216.Google Scholar
  24. 24.
    Zahavi I, Weizen T, Marcus H, Karmeli F, Dinari G. Ketotifen is protective against indomethacin-induced intestinal ulceration in the rat. Isr J Med Sci 1996;32:312–315.PubMedGoogle Scholar
  25. 25.
    Niu XF, Ibbotson G, Kubes P. A balance between nitric oxide and oxidants regulate mast cell dependent neutrophil-endothelial cell interaction. Circ Res 1996;79:992–999.PubMedGoogle Scholar
  26. 26.
    Heyman SN, Karmeli F, Brezis M, Rachmilewitz D. The effects of ketotifen on nitric oxide synthese activity. Br J Pharmacol 1997;120:1545–1551.PubMedCrossRefGoogle Scholar
  27. 27.
    Hogaboam CM, Befus AD, Wallace JL. Modulation of rat mast cell reactivity by IL-1B-divergent effects of nitric oxide and platelet activating factor release. J Immunol 1993;151:3767–3774.PubMedGoogle Scholar
  28. 28.
    Kubes P, Granger DN. Leukocyte endothelial cell interaction invoked by mast cells. Cardiovasc Res 1996;32:699–708.PubMedGoogle Scholar
  29. 29.
    Werner J, Fernandez J, Rattner DW, Warchaw AL. Technetium-99m-labeled white blood cells. New method to define the local and systemic role of leukocytes in acute experimental pancreatitis. Ann of Surgery 1998;227(1):86–94.CrossRefGoogle Scholar
  30. 30.
    Galli SJ. New concepts about the mast cells. N Engl J Med 1993;328:257–265.PubMedCrossRefGoogle Scholar
  31. 31.
    Molero X, Guarner F, Salas A, Mourelle M, Puig V, Malagelada JR. Nitric oxide modulates pancreatic basal secretion and response to cerulein in the rat: effects in acute pancreatitis. Gastroenterology 1995;108:1855–1862.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2002

Authors and Affiliations

  • Nadir Yönetçi
    • 1
  • Nevin Oruç
    • 4
    Email author
  • A. Ömer Özütemiz
    • 4
  • Handan Ak çelik
    • 2
  • Gül Yüce
    • 3
  1. 1.Department of Gastroenterology-DenizliPamukkale UniversityTurkey
  2. 2.Ege University Department of BiochemistryTurkey
  3. 3.Ege University Department of Pathology-IzmirTurkey
  4. 4.Faculty of Medicine, Gastroenterology Department, Izmir-TurkeyEge UniversityBornova-IzmirTurkey

Personalised recommendations